CIK 0001506251 · Non-accelerated filer<br>Smaller reporting company
Citius Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CTXR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273425913
- Phone
- (908) 967-6676
- Business address
- 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
- Former names
- Trail One, Inc., TrailOne, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-08 | Bartushak Jaime Chief Financial Officer | Grant or award · Stock Option (Right to Purchase Common Stock) | +100,000 | 100,000 | ||
| 2019-09-27 | Mazur Leonard L Executive Chairman | Purchase | +2,234,700 | $0.90 | $2.0M | 10,255,343 |
| 2019-09-27 | Mazur Leonard L Executive Chairman | Purchase · Warrant to Purchase Common Stock | +2,234,700 | 2,234,700 | ||
| 2019-09-27 | HOLUBIAK MYRON Z President and CEO | Purchase | +558,597 | $0.90 | $500K | 1,992,243 |
| 2019-09-27 | HOLUBIAK MYRON Z President and CEO | Purchase · Warrant to Purchase Common Stock | +558,597 | 558,597 | ||
| 2019-04-03 | Mazur Leonard L Executive Chairman | Purchase | +1,165,048 | $1.55 | $1.8M | 8,020,643 |
| 2019-04-03 | Mazur Leonard L Executive Chairman | Purchase · Warrant to Purchase Common Stock | +1,165,048 | 1,615,048 | ||
| 2019-04-03 | HOLUBIAK MYRON Z President and CEO | Purchase | +129,450 | $1.55 | $200K | 1,433,646 |
| 2019-04-03 | HOLUBIAK MYRON Z President and CEO | Purchase · Warrant to Purchase Common Stock | +129,450 | 129,450 | ||
| 2018-09-04 | Webb Carol Director | Grant or award · Options to Purchase Common Stock | +15,000 | 15,000 | ||
| 2018-09-04 | SAFIR HOWARD Director | Grant or award · Options to Purchase Common Stock | +15,000 | 15,000 | ||
| 2018-09-04 | Mazur Leonard L Executive Chairman | Grant or award · Options to Purchase Common Stock | +150,000 | 150,000 | ||
| 2018-09-04 | Kane William Director | Grant or award · Options to Purchase Common Stock | +15,000 | 15,000 | ||
| 2018-09-04 | Holuka Eugene Myron Director | Grant or award · Options to Purchase Common Stock | +15,000 | 15,000 | ||
| 2018-09-04 | HOLUBIAK MYRON Z President and CEO | Grant or award · Options to Purchase Common Stock | +150,000 | 150,000 | ||
| 2018-09-04 | Dutia Suren G Director | Grant or award · Options to Purchase Common Stock | +15,000 | 15,000 | ||
| 2018-09-04 | Bartushak Jaime Chief Financial Officer | Grant or award · Stock Option (Right to Purchase Common Stock) | +70,000 | 70,000 | ||
| 2018-08-13 | Mazur Leonard L Executive Chairman | Purchase | +3,137,255 | $1.28 | $4.0M | 6,855,595 |
| 2018-08-13 | Mazur Leonard L Executive Chairman | Grant or award · Warrant to Purchase Common Stock | +3,137,255 | 3,137,255 | ||
| 2018-08-13 | HOLUBIAK MYRON Z President and CEO | Purchase | +784,314 | $1.28 | $1.0M | 1,304,196 |
Page 6 of 8 · 156 trades